Peng Yuan, Ye Hongjian, Yi Chunyan, Xiao Xi, Huang Xuan, Liu Ruihua, Diao Xiangwen, Mao Haiping, Yu Xueqing, Yang Xiao
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.
Clin Kidney J. 2020 Dec 12;14(6):1649-1656. doi: 10.1093/ckj/sfaa214. eCollection 2021 Jun.
The effect of early initiation of dialysis on outcomes of patients with end-stage renal disease (ESRD) remains controversial. We conducted this study to investigate the association between the timing of peritoneal dialysis (PD) initiation and mortality in different age groups.
In this single-centre cohort study, incident patients receiving PD from 1 January 2006 to 31 December 2016 were enrolled. Patients were categorized into three groups according to the estimated glomerular filtration rate (eGFR) at the initiation of PD, with early, mid and late initiation of PD defined as eGFR ≥7.5, 5-7.5 and <5 mL/min/1.73 m, respectively.
A total of 2133 incident patients receiving PD were enrolled with a mean age of 47.1 years, 59.6% male and 25.3% with diabetes, of whom 1803 were young (age <65 years) and 330 were elderly (age ≥65 years). After multivariable adjustment, the overall and cardiovascular (CV) mortality risks for young patients receiving PD were not significantly different between these three groups. However, for elderly patients, early initiation of PD therapy was associated with increased risks of all-cause {hazard ratio [HR} 1.54 [95% confidence interval (CI) 1.06-2.25]} and CV [HR 2.07 (95% CI 1.24-3.48)] mortality compared with late initiation of PD, while no significant difference was observed in overall or CV mortality between the mid- and late-start groups.
No significant difference in mortality risk was found among the three levels of eGFR at PD therapy initiation in young patients, while early initiation of PD was associated with a higher risk of overall and CV mortality among elderly patients.
早期开始透析对终末期肾病(ESRD)患者预后的影响仍存在争议。我们开展本研究以调查不同年龄组中腹膜透析(PD)开始时机与死亡率之间的关联。
在这项单中心队列研究中,纳入了2006年1月1日至2016年12月31日期间开始接受PD治疗的新发病例患者。根据PD开始时的估计肾小球滤过率(eGFR)将患者分为三组,PD早期、中期和晚期开始分别定义为eGFR≥7.5、5 - 7.5和<5 mL/min/1.73 m²。
共纳入2133例接受PD治疗的新发病例患者,平均年龄47.1岁,男性占59.6%,糖尿病患者占25.3%,其中1803例为年轻患者(年龄<65岁),330例为老年患者(年龄≥65岁)。经过多变量调整后,这三组中接受PD治疗的年轻患者的总体和心血管(CV)死亡风险无显著差异。然而,对于老年患者,与晚期开始PD治疗相比,早期开始PD治疗与全因死亡风险增加相关{风险比[HR] 1.54 [95%置信区间(CI)1.06 - 2.25]}以及CV死亡风险增加相关[HR 2.07(95% CI 1.24 - 3.48)],而中期和晚期开始组之间在总体或CV死亡率方面未观察到显著差异。
在年轻患者中,PD治疗开始时的三个eGFR水平之间未发现死亡风险有显著差异,而在老年患者中,早期开始PD治疗与总体和CV死亡风险较高相关。